ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
The Impact of Heating, Ventilation, and Air-Conditioning Design Features on the Transmission of Viruses, Including SARS-CoV-2: Overview of Reviews
This article has 5 authors:Reviewed by ScreenIT
-
Modeling SARS-CoV-2 RNA degradation in small and large sewersheds
This article has 10 authors:Reviewed by ScreenIT
-
Exploring the Spatially Heterogeneous Effects of the Built Environment on Bike-Sharing Usage during the COVID-19 Pandemic
This article has 5 authors:Reviewed by ScreenIT
-
Supramolecular Organization of SARS-CoV and SARS-CoV-2 Virions Revealed by Coarse-Grained Models of Intact Virus Envelopes
This article has 3 authors:Reviewed by ScreenIT
-
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial
This article has 13 authors:Reviewed by ScreenIT
-
Association of inflammatory markers with severity of disease and mortality in COVID-19 patients: a systematic review and meta-analysis
This article has 6 authors:Reviewed by ScreenIT
-
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
This article has 47 authors:Reviewed by ScreenIT
-
Blood biochemical parameters as predictors of disease severity and mortality in COVID-19 patients- an updated systematic review and meta-analysis
This article has 6 authors:Reviewed by ScreenIT
-
Characterisation of the blood RNA host response underpinning severity in COVID-19 patients
This article has 105 authors:Reviewed by ScreenIT
-
EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL
This article has 26 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT